Eli Lilly's Mounjaro diabetes and weight-loss drug approved in India in KwikPen device, offering personalized treatment ...

Signs of advanced chronic pancreatitis include weight loss, a loss of appetite, jaundice, other symptoms associated with ...

A leading UK eating disorder clinic has issued an urgent warning about the growing dangers of online access to buying weight ...

India’s drug regulator has given the nod to Eli Lilly’s once-a- week Mounjaro (tirzepatide) injection in the KwikPen format, ...

The UK is investigating a rise in acute pancreatitis cases linked to GLP-1 weight-loss drugs, exploring possible genetic ...

A clinical trial has shown that Ozempic improves blood glucose levels and weight loss in overweight type 1 diabetics who use ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

They go by various names but the injections work by curbing appetite, lowering blood sugar and slowing food digestion.

To address this, researchers tested a new strategy: combining semaglutide (the active ingredient in Ozempic and Wegovy) with an experimental drug called bimagrumab. Bimagrumab is a lab-made antibody ...

SPRINGFIELD, Mo. (KY3) - Should you try a GLP-1 weight loss drug or surgery? Dr. Tim Woods of CoxHealth shares advice for ...

Orforglipron is an oral drug from Eli Lilly that’s in trial stage. The New York Times reports that in a trial of over 500 ...